Edition:
United States

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

7.31USD
15 Nov 2018
Change (% chg)

$0.32 (+4.58%)
Prev Close
$6.99
Open
$6.94
Day's High
$7.36
Day's Low
$6.93
Volume
161,675
Avg. Vol
192,194
52-wk High
$8.30
52-wk Low
$4.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.24 December 15 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 3 3 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.33 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 7 2.93 4.08 0.00 2.75
Year Ending Dec-18 8 20.62 22.00 18.00 20.33
Year Ending Dec-19 8 10.62 17.76 0.10 21.20
Earnings (per share)
Quarter Ending Dec-18 8 -0.24 -0.18 -0.27 -0.20
Year Ending Dec-18 8 -0.96 -0.76 -1.02 -0.76
Year Ending Dec-19 8 -1.00 -0.89 -1.10 -0.76

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 3.98 1.45 2.52 63.45
Quarter Ending Jun-18 3.52 12.49 8.97 254.75
Quarter Ending Mar-18 6.04 3.98 2.06 34.16
Quarter Ending Dec-17 4.93 3.89 1.04 21.03
Quarter Ending Sep-17 4.62 8.76 4.14 89.47

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 2.93 3.55 4.42 4.99 2.75
Year Ending Dec-18 20.62 20.62 26.93 26.84 20.33
Year Ending Dec-19 10.62 12.03 14.68 17.84 21.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 3 2 2 5
Year Ending Dec-18 0 0 2 6
Year Ending Dec-19 3 4 1 6
Earnings